Quote:
NanoTech Gaming and High Velocity Acquisition
We recently announced the acquisition of High Velocity Enterprises, Inc.. High Velocity is a separate public company currently trading under the symbol HVEL. NanoTech has taken over control of the company and management. Bruce Schoengood has resigned from the company and Board of Directors and is no longer affiliated with the company. Alan Stone has been named
the Chairman and CEO of the company.
HVEL has purchased the assets of NanoTech Gaming Labs from NanoTech. For that acquisition NTEK has been issued shares in HVEL. NTEK will be distributing those shares, upon registration and approval to its shareholders based upon their holdings in NTEK as of the close of market today, February 6, 2015. NTEK will record all shareholders of NTEK stock and their holdings and use that as the basis for distribution of shares. A timeline cannot be given as the
registration and issuance of HVEL shares is controlled by the SEC.
HVEL will be renamed to NanoTech Gaming, and have its ticker changed to reflect the name change. Shares are being registered with the SEC and will be free trading upon approval of their issuance. HVEL is being audited and we anticipate that the audits and applications for registration with the SEC and up listing to OTCQB will take place in the next 90 days.
Current HVEL shareholders are gaining the benefit of the acquisition of world class patent pending technology that is groundbreaking in the gaming field. NanoTech Gaming will be operated independently of NTEK.
HVEL Authorized Shares is 45,000,000 not 45,000,000,000 as incorrectly reported on OTC Markets. We have notified OTC Markets of the many updates to the company and are waiting for them to correct their website. OTC Markets information is published by the company and is not the official location of Authorized Shares. That can be found on the Nevada State website
where the articles of incorporation must be filed along with any changes to the share structure.
The NTGL share distribution is for NTEK shareholders on
Top 10 Most Recent News Articles
Ris-Rez May Set New Standard in Relapsed SCLC
The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...
Continue Reading
Trial Disappointment: No Significant Gains in NSCLC
Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...
Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights
Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...
Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse
Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...
Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors
The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...
Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms
Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...
Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care
Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....
Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency
The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...
Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance
Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...
Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star
GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...
Continue ReadingTop 5 Most Recently Viewed Articles
Thor Equities Sells Amazon Distribution Center for $157M
Thor Equities Group Successfully Transacts Major Sale Thor Equities Group, recognized as a leader in urban real estate development and management, has successfully concluded the sale of a significant industrial property. The property, located at 280 Richards Street in Brooklyn, was sold for an impressive $157 million. Details of the 280 Richards Street Property This...
Continue Reading
Exploring the Dynamics of Cloud Object Storage Growth and Demand
Understanding Cloud Object Storage Market Evolution The growth of the Cloud Object Storage Market is driven by the exponential rise in unstructured data, increasing adoption of cloud-based services, and the need for scalable, cost-effective storage solutions across industries. Enterprises are rapidly shifting toward hybrid and multi-cloud strategies, boosting demand for...
Continue Reading
Danone's Strategic Acquisition of Kate Farms to Drive Growth
Danone Strengthens U.S. Nutrition Offerings with Kate Farms Purchase In a significant move for its health-focused division, Danone has officially finalized the acquisition of a majority stake in Kate Farms. This acquisition positions Danone as a key player in the specialized nutrition market by integrating Kate Farms’ lineup of plant-based, organic nutrition products....
Continue Reading
GSK plc Faces Class Action Over Zantac and Investor Rights
Rosen Law Firm Encourages GSK plc Investors to Take Action Rosen Law Firm, renowned for advocating investor rights, is reaching out to shareholders of GSK plc (NYSE: GSK). The firm has been alerted to a class action alleging that GSK misrepresented crucial information regarding its business operations during the class period from February 5, 2020, to August 14, 2022....
Continue Reading
Alibaba's Recent Stock Surge Driven by Cloud Innovation
Alibaba Group Holding Ltd's Stock Performance Alibaba Group Holding Ltd (NASDAQ: BABA) recently saw its shares soar by an impressive 18.5% on the Hong Kong Stock Exchange. This spike occurred amid high expectations following a solid quarterly performance from the company’s cloud computing division alongside the launch of a new artificial intelligence chip. Investors are...
Continue Reading